Skip to main content
. 2021 Jun 2;37:107191. doi: 10.1016/j.dib.2021.107191

Fig. 1.

Fig. 1

Overview of number of patients with available genetic and histological data and the overlap between different groups. The WHO 2016 subtype is available for the 222 patients for which the IDH mutation status, 1p/19q co-deletion status, and tumor grade is known and for the 193 patients for which the IDH mutation status and tumor grade is known.